CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting

Contributed by: Business Wire

Tags

Health

Surgery

Genetics

Managed Care

General Health

Cardiology

Biotechnology

CareDx, Inc.

More Like This

CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients

International Research Collaboration Aims to Personalise Prevention and Treatment of Cardiovascular Diseases

PR Newswire associated0

Caristo to Unveil New Clinical and Research Results at SCCT 2025

Alnylam to Present Detailed Results from the HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress 2024

PR Newswire associated0

The Lancet Publishes Results from World's Largest Coronary CT Registry Showing New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation At Least 10 Years in Advance

PR Newswire associated0

CardiaCare Completes Seed Extension Raise to Support Clinical Pilot Studies

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024

Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting